Adjuvant Global Health Technology Fund, L.P.

SEC source: 0000950170-24-005513 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 377,542

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-24-005513 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,995,958

F1 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-064611 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Plan reported

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 393,449

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.285, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-064611 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,080,051

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.285, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-051728 · ownership.xml · nonDerivative · entry 4

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 393,737

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-051728 · ownership.xml · nonDerivative · entry 3

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,081,573

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-051728 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 394,639

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.95, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-051728 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,086,343

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.95, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-050853 · ownership.xml · nonDerivative · entry 4

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P

Disclosed balance after: 410,403

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-050853 · ownership.xml · nonDerivative · entry 3

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,169,680

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-050853 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P

Disclosed balance after: 411,759

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.14, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-050853 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,176,840

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.14, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-048422 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.(

Disclosed balance after: 411,893

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-048422 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,177,547

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-047312 · ownership.xml · nonDerivative · entry 4

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.(

Disclosed balance after: 411,957

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.25, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-047312 · ownership.xml · nonDerivative · entry 3

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,177,883

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.25, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-047312 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.(

Disclosed balance after: 412,494

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-047312 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,180,724

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.00 to $16.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-044594 · ownership.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 413,092

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000950170-23-044594 · ownership.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,183,888

F1 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024050 · doc4.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 413,156

F1 · kind: On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.

F1 · price: On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.

F3 · ownership.nature: Shares held directly by AGHT Fund DE. The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024050 · doc4.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,184,224

F1 · kind: On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.

F1 · price: On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.

F2 · ownership.direct: Shares held directly by AGHT Fund. The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · derivative · entry 9

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 74,230 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · derivative · entry 8

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 392,433 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · derivative · entry 7

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 312,415 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · derivative · entry 6

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,651,636 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · nonDerivative · entry 5

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund, L.P.

Disclosed balance after: 2,210,735

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · nonDerivative · entry 4

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 386,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · nonDerivative · entry 3

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund, L.P.

Disclosed balance after: 2,044,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 312,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-012990 · doc4.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund, L.P.

Disclosed balance after: 1,651,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · derivative · entry 9

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 74,230 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · derivative · entry 8

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 392,433 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · derivative · entry 7

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 312,415 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · derivative · entry 6

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,651,636 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.exercise_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F1 · derivative.expiration_date: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · nonDerivative · entry 5

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,210,735

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · nonDerivative · entry 4

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 386,645

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · nonDerivative · entry 3

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,044,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · nonDerivative · entry 2

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Adjuvant Global Health Technology Fund DE, L.P.

Disclosed balance after: 312,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F3 · ownership.nature: Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.

SEC source: 0000899243-22-024034 · doc4a.xml · nonDerivative · entry 1

Adjuvant Global Health Technology Fund, L.P. · CIK 0001783165 · 10% owner

Adjuvant Global Health Technology Fund DE, L.P. · CIK 0001799812 · 10% owner

Adjuvant Capital GP, L.P. · CIK 0001935100 · 10% owner

Adjuvant Capital Management, LLC · CIK 0001935084 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,651,636

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.

F2 · ownership.direct: Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.